Delivery Order SPE2DR25D2005-SPE2DR26FF1V0
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Lidocaine 5% patches (30-count units) with a contract ceiling value of $19,557.11. This firm fixed-price delivery order, with an ultimate completion date of January 30, 2026, is unclassified as a set-aside contract and represents a competitive award to the pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $4,573.18. This is a firm fixed price delivery order with an ultimate completion date of November 17, 2025, representing a child order under AmerisourceBergen's larger contract vehicle. The award was made through open competition with no set-aside designation, and performance will be executed from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 19, 2026, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $8,366.56 with an ultimate completion date of January 20, 2026, represents a competitively awarded procurement with no set-aside designation. The award was fulfilled from the place of performance in Conshohocken, Pennsylvania, where Amerisourcebergen...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Lidocaine 5% Patch 30-count units, with a ceiling value of $10,834.22 and firm fixed pricing. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 17, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerSourceBergen Drug Corp (a subsidiary of Cencora, Inc.) on January 16, 2026, for the supply of Lidocaine 5% patches in quantities of 30, with a ceiling value of $1,545.71. This is a firm fixed-price delivery order with an ultimate completion date of January 20, 2026, and no set-aside designation was used. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Lidocaine 5% Patch 30s, with a ceiling value of $2,285.28 and an ultimate completion date of January 6, 2026. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $2,121.12. This is a firm fixed-price delivery order with an ultimate completion date of October 22, 2025, and represents a non-competitive set-aside award. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Lidocaine patches are topical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,029.81 and an ultimate completion date of August 18, 2025. The contract involves no set-aside designation, indicating it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $11,050.88 and an ultimate completion date of September 24, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (subsidiary of parent company Cencora, Inc.) on January 28, 2026, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $1,280.53, represents a non-set-aside award made through open competition and is scheduled for completion by January 29, 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FF1V0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 27, 2026, for the supply of Lidocaine 5% patches in quantities of 30 units, with a contract ceiling value of $13,438.74. This is a firm fixed-price delivery order with an ultimate completion date of January 28, 2026, and the work will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's established capability to meet federal procurement requirements. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at up to $999,999,999.00 through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, generic and brand-name drugs, vaccines, and medical devices across multiple therapeutic domains. The contract supports critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.4k | 1/26/26 |